Anika Therapeutics reported $41.37M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 59.48M 9.66M
Adamas Pharmaceuticals ADMS:US 21.82M 7.35M
Agenus AGEN:US $ 168.75M 30.38M
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
Anika Therapeutics ANIK:US $ 41.37M 5.61M
Arrowhead Research ARWR:US $ 195.43M 28.25M
Chemocentryx CCXI:US $ 55.38M 0.65M
Clovis Oncology CLVS:US $ 173.88M 0.64M
Dicerna Pharmaceuticals DRNA:US $ 207.65M 25.5M
Enanta Pharmaceuticals ENTA:US $ 28.62M 2.01M
Flexion Therapeutics FLXN:US $ 39.93M 18.05M
Halozyme Therapeutics HALO:US $ 114.25M 6.83M
Heron Therapeutics HRTX:US $ 82.14M 18.77M
Immunogen IMGN:US $ 120.32M 14.03M
Insmed INSM:US $ 99.66M 18.26M
Intrexon XON:US $ 28.87M 3.63M
Karyopharm Therapeutics KPTI:US $ 58.12M 3.88M
Ligand Pharmaceuticals LGND:US $ 52.5M 43.31M
Macrogenics MGNX:US $ 69.92M 16.88M
Merit Medical Systems MMSI:US $ 210.6M 2.93M
Peregrine Pharmaceuticals PPHM:US $ 63.25M 7.69M
Rigel Pharmaceuticals RIGL:US $ 59.54M 7.52M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Stryker SYK:US $ 4252M 299M
Surmodics SRDX:US $ 17.66M 1.96M
Veracyte VCYT:US $ 36.1M 3.4M
Xencor XNCR:US $ 45.96M 53.97M
Zimmer Biomet Holdings Inc ZBH:US $ 2.93B 839.1M